Early evaluation of tumor response to 90Y-ibritumomab radioimmunotherapy in relapsed/refractory B cell non-Hodgkin lymphoma: what is the optimal timing for FDG-PET/CT?

Purpose: To determine the earliest optimal timing for assessment of early response following radioimmunotherapy in non-Hodgkin lymphoma patients using FDG-PET/CT.Methods: FDG-PET/CT was performed prior to treatment (PET1), at 2 (PET2) weeks, and at 6 (PET3) weeks after 90Y-ibritumomab radioimmunothe...

Full description

Bibliographic Details

Published in:	European Radiology Vol. 29; no. 7; pp. 3935 - 3945
Main Authors:	Kitajima, Kazuhiro, Okada, Masaya, Kashiwagi, Toru, Yoshihara, Kyoko, Tokugawa, Tazuko, Sawada, Akihiro, Yoshihara, Satoshi, Fujimori, Yoshihiro, Yamakado, Koichiro
Format:	Journal Article
Published:	Springer Nature Jul2019
Online Access:	View this record in EBSCOhost